Novo Nordisk’s Pill Strategy Gets a Double Boost – EU Nod and Analyst Upgrade – Yet the Growth S
Novo Nordisk shares have recouped more than 40% from their early-March low, but the stock still sits nearly…
Berlin’s About-Face on Commerzbank Gets Tangled in a Two-Year Regulatory Maze
The political resistance to UniCredit’s creeping control of Commerzbank is crumbling, but the path to full ownership remains…
Novo Nordisk Gets Hemophilia Boost as CagriSema Device Pause Stays in the Background
Novo Nordisk shares are staging a recovery from March’s 52-week trough, supported by encouraging late-stage hemophilia data and…
Novo Nordisk’s Oral Wegovy Gets UK Nod as Cyber Breach Casts a Shadow
It has been a year since Novo Nordisk’s shares touched an all-time high above €70. Now trading at…
Valentine’s Day gets a creative twist
Valentine’s Day, often marked by bouquets and boxed chocolates, is getting a creative update as The Lego Group…